Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation ACC 2022

A Randomized Trial To Confirm The Safety And Effectiveness Of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter In Above The Knee Lesions

Presenter: Alexandra Lansky

April 04, 2022

News Conference News ACC 2022

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

L.A. McKeown

April 04, 2022

News Daily News

Female-Specific Data Lacking for Myocardial Revascularization: SCAI

Todd Neale

February 08, 2022

News Conference News EuroPCR 2021

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

Caitlin E. Cox

May 24, 2021

News Conference News

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

Shelley Wood

November 19, 2020

News Conference News EuroPCR 2019

EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal

L.A. McKeown

May 23, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Industry News

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

June 22, 2017

News Industry News

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

February 24, 2016

News Industry News

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

December 08, 2015

News Industry News

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

May 19, 2015

Presentation TCT 2012

First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

Presenter: Bo Xu, Jie Qian, Alexandra J. Lansky, Yuejin Yang, Shubin Qiao, Yongjian Wu, Jue Chen, Fenghuan Hu, Weixian Yang, Gary S. Mintz, Martin B. Leon, Run-Lin Gao

January 03, 2012

Presentation TCT 2012

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

Presenter: John Ormiston, William Wijns, Charlene Knape, Mathias Vrolix, James Stewart, Mark Webster, Robert Whitbourn, Alexandra Lansky, Hiram Bezzera, Peter Fitzgerald, David Kandzari

January 03, 2012

News Daily News

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Leah Lawrence

February 03, 2011

Advertisement

A Randomized Trial To Confirm The Safety And Effectiveness Of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter In Above The Knee Lesions

Second-Generation Chocolate Touch DCB Bests Lutonix for Patency in PAD

Female-Specific Data Lacking for Myocardial Revascularization: SCAI

Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate

‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III

EFFPAC: Novel Paclitaxel DCB for PAD Demonstrates Efficacy With No Mortality Signal

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

TriReme Medical Reports Negative Late Lumen Loss At 24-Month Angiographic Follow-Up For Chocolate Heart™ Drug-Coated Coronary Balloon

Micell Technologies Highlights Data From Published Propensity Analysis of MiStent SES® and Market Standard Xience V® Coronary Stent

Micell Technologies Announces Completion of Enrollment in MiStent Randomized Trial Against Xience

EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment

First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

DESSOLVE I FIH Trial of the MiStent® DES: Sirolimus Eluted from an Absorbable Polymer on a Thin Strut Stent is Highly Efficacious.

Superiority of Xience V Over Taxus in Women Sustained at 3 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content